Pharmapedia Pro
Medicines/Generics/Gliclazide

Gliclazide

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Gliclazide is a sulfonyl urea compound. Gliclazide is oral hypoglycemic agent and effective in the treatment of non-insulin dependent diabetes. Gliclazide is used in conjunction with proper diet and exercise to decrease blood sugar levels. It also reduces the cardiovascular complications of diabetic patient.
Indications
Gliclazide is primarily indicated in conditions like Diabetes mellitus type-II.
Contraindications
Gliclazide is contraindicated in conditions like IDDM, Ketosis.
Side Effects
The severe or irreversible adverse effects of Gliclazide, which give rise to further complications include GI symptoms, Liver problems, Dermatological reactions, Hypoglycemia. Gliclazide produces potentially life-threatening effects which include Hypoglycemia, Brain damage, which are responsible for the discontinuation of Gliclazide therapy. The signs and symptoms that are produced after the acute overdosage of Gliclazide include Hypoglycemia, Cerebral edema. The symptomatic adverse reactions produced by Gliclazide are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Vomiting, Skin rashes, GI upset, Abdominal pain
Warnings
Should not be used in severe renal impairment. Not recommended in pregnancy.
High Risk Groups
Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Liver Malfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
40 to 80 mg (60 (60)) 24 hourly PO — Max dose 320 mg. doses > 160 mg given in 2 divided doses.
Child Dosage
( ) — Not recommended in this age group
Neonatal Dosage
( ) — Not recommended in this age group
Drug Interactions
Gliclazide is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAlcoholAspirinClofibrateDiazoxidePhenylbutazone RifampicinSulphamethizoleGliclazide may be displaced from protein binding sites or their metabolism may be inhibited by some sulfonamides, resulting in increased or prolonged effects or toxicity.Dosage adjustments may be necessary during and after sulfonamide therapy These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Storage
Tab Store in a well closed container, Below 40°C. Protect from Sunlight.

Available Brands in Pakistan

41 active brands listed alphabetically.

APTIZID

Active

APTCURE PRIVATE LIMITED

DML: APTIZID

Tabs

AZIDE

Active

ATCO LABORATORIES LIMITED

DML: AZIDE

Tabs

DB-ZIDE

Active

EPOCH PHARMACEUTICAL

DML: DB-ZIDE

Tabs

DIABETRON

Active

FEROZSONS LABORATOIES LTD.

DML: DIABETRON

Tabs

DIABO

Active

PARKE DAVIS & COMPANY LTD.

DML: DIABO

Tabs

DIAGLIC

Active

EPLA LABORATORIES (PVT) LTD.

DML: DIAGLIC

Tabs

DIAMICRON

Active

SERVIER RESEARCH & PHARMACEUTICALS PAKISTAN (PVT) LTD.

DML: DIAMICRON

Tabs

DIAMICRON-MR

Active

SERVIER RESEARCH & PHARMACEUTICALS PAKISTAN (PVT) LTD.

DML: DIAMICRON-MR

Tabs

DIAMIDE

Active

EPLA LABORATORIES (PVT) LTD.

DML: DIAMIDE

Tabs

DIANEXT

Active

NEUTRO PHARMA (PVT) LTD.

DML: DIANEXT

Tabs

DIARON

Active

ALBRO PHARMA

DML: DIARON

Tabs

DICLAZIDE

Active

WILSONS PHARMACEUTICALS

DML: DICLAZIDE

Tabs

DIOCID

Active

HIMONT PHARMACEUTICALS (PVT) LTD.

DML: DIOCID

Tabs

DIOZIDE

Active

MEDIPAK LIMITED

DML: DIOZIDE

Tabs

FYMICRON

Active

FYNK PHARMACEUTICALS

DML: FYMICRON

Tabs

GETZID MR

Active

GETZ PHARMA PAKISTAN (PVT) LTD.

DML: GETZID MR

Tabs

GLARE TAB

Active

MASS PHARMA (PRIVATE) LIMITED

DML: GLARE TAB

Tabs

GLAZE

Active

MEDISURE LABORATORIES PAKISTAN (PVT.) LTD.

DML: GLAZE

Tabs

GLAZID

Active

NOVA MED PHARMACEUTICALS

DML: GLAZID

Tabs

GLICLAMED

Active

MEDIATE PHARMACEUTICALS (PVT) LTD

DML: GLICLAMED

Tabs

GLICLAZIDE

Active

ENGLISH PHARMACEUTICALS INDUSTRIES

DML: GLICLAZIDE

Tabs

GLICOTRON

Active

NABIQASIM INDUSTRIES (PVT) LTD.

DML: GLICOTRON

Tabs

GLIDE

Active

MEGA PHARMACEUTICALS (PVT) LTD

DML: GLIDE

Tabs

GLIMICRON

Active

UNIMARK PHARMACEUTICALS

DML: GLIMICRON

Tabs

GLIMIN

Active

NOVA MED PHARMACEUTICALS

DML: GLIMIN

Tabs

GLIMIN FORTE

Active

BEX PHARMA (PVT) LTD.

DML: GLIMIN FORTE

Tabs

GLINEXT

Active

PAKISTAN PHARMACEUTICAL PRODUCTS (PVT) LTD.

DML: GLINEXT

Tabs

GLINEXT

Active

BEX PHARMA (PVT) LTD.

DML: GLINEXT

Tabs

GLIZID-80

Active

VALOR PHARMACEUTICALS

DML: GLIZID-80

Tabs

GLUCOFEND

Active

FRIENDS PHARMA (PVT) LTD

DML: GLUCOFEND

Tabs

MACAZID

Active

MACTER INTERNATIONAL (PVT) LTD.

DML: MACAZID

Tabs

NIDONIL

Active

MARTIN DOW PHARMACEUTICALS (PAK) LTD.

DML: NIDONIL

Tabs

NODIBET

Active

STANDPHARM PAKISTAN (PVT) LTD.

DML: NODIBET

Tabs SRTabs

PROTECT

Active

PLATINUM PHARMACEUTICALS (PVT.) LTD.

DML: PROTECT

Tabs

SCICON MR

Active

SCILIFE PHARMA (PRIVATE) LTD

DML: SCICON MR

Tabs

SUCRONIL

Active

HELICON PHARMACEUTEK PAKISTAN (PVT) LTD.

DML: SUCRONIL

Tabs

SUGCON

Active

ALINA COMBINE PHARMACEUTICALS (PVT) LTD.

DML: SUGCON

Tabs

TAGAMICRON

Active

TAGMA PHARMA (PVT) LTD.

DML: TAGAMICRON

Tabs

TRYMICRON MR

Active

EVEREST PHARMACEUTICALS

DML: TRYMICRON MR

Tabs

ZACLAZIDE

Active

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD.

DML: ZACLAZIDE

Tabs

ZENZIDE

Active

JAWA PHARMACEUTICALS(PVT) LTD.

DML: ZENZIDE

Tabs

9 additional records are present but flagged "Unverified / Legacy" and not listed.